US “urgently” needs new ways to incentivise pharma

Posted On 23 Apr 2014
By :

US policymakers need to urgently find new ways to incentivise pharmaceutical companies and device makers to develop products that produce more value, to help rein in massive healthcare spending, says a new report. To help reduce invention costs, the National Institutes of Health (NIH) – the major US funder of basic biomedical health – should encourage more creativity and risk-taking to promote major scientific breakthroughs, adds the study, from policy research group RAND Health.

Read the source article at PharmaTimes

About the Author

Leave a Reply